EVAN CARDIN: Open Payments
NPI 1447888649 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 20 payments from 10 companies in 2025. Trend: 2023 $577 · 2024 $515 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $222 |
| BIOTRONIK INC. | 1 | $64 |
| PFIZER INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
| ABIOMED | 1 | $14 |
Products named: AVEIR, BIOMONITOR, VYNDAQEL, FARXIGA, SHINGRIX, Varithena Administration Pack, JOT DX, Repatha.
Industry payments across NJ — which companies pay providers there.
